Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −15,337−100.0% | Sold out | Holders |
| Q2 2025 | 15,337 | $257.0K | <0.1% | +15,337 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −18,792−100.0% | Sold out | Holders |
| Q3 2024 | 18,792 | $338.6K | <0.1% | −2,036,723−99.1% | Reduced | Holders |
| Q2 2024 | 2,055,515 | $33.4M | 0.1% | −377,752−15.5% | Reduced | Holders |
| Q1 2024 | 2,433,267 | $34.3M | 0.1% | −846,794−25.8% | Reduced | Holders |
| Q4 2023 | 3,280,061 | $34.2M | 0.2% | −184,146−5.3% | Reduced | Holders |
| Q3 2023 | 3,464,207 | $35.3M | 0.2% | −85,576−2.4% | Reduced | Holders |
| Q2 2023 | 3,549,783 | $26.7M | 0.1% | +301,583+9.3% | Added | Holders |
| Q1 2023 | 3,248,200 | $28.7M | 0.1% | −502,100−13.4% | Reduced | Holders |
| Q4 2022 | 3,750,300 | $34.2M | 0.2% | +437,400+13.2% | Added | Holders |
| Q3 2022 | 3,312,900 | $26.7M | 0.2% | −151,800−4.4% | Reduced | Holders |
| Q2 2022 | 3,464,700 | $26.1M | 0.1% | −11,400−0.3% | Reduced | Holders |
| Q1 2022 | 3,476,100 | $32.6M | 0.2% | +700,500+25.2% | Added | Holders |
| Q4 2021 | 2,775,600 | $22.2M | 0.1% | −30,100−1.1% | Reduced | Holders |
| Q3 2021 | 2,805,700 | $27.3M | 0.1% | +252,800+9.9% | Added | Holders |
| Q2 2021 | 2,552,900 | $25.3M | 0.1% | +559,000+28.0% | Added | Holders |
| Q1 2021 | 1,993,900 | $23.0M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.